Patent details
EP1365776 Title: USE OF AN ADENOSINE A3 RECEPTOR AGONIST FOR INHIBITION OF VIRAL REPLICATION
Basic Information
- Publication number:
- EP1365776
- PCT Application Number:
- PCT/IL/2002/000028
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP027295070
- PCT Publication Number:
- WO/2002/055085
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF AN ADENOSINE A3 RECEPTOR AGONIST FOR INHIBITION OF VIRAL REPLICATION
- French Title of Invention:
- UTILISATION D'UN AGONISTE DU RECEPTEUR A3 D'ADENOSINE POUR L'INHIBITION DE REPLICATION VIRALE
- German Title of Invention:
- VERWENDUNG EINES ADENOSIN-A3-REZEPTOR-AGONISTEN ZUR HEMMUNG DER VIRENREPLIKATION
- SPC Number:
Dates
- Filing date:
- 13/01/2002
- Grant date:
- 13/04/2005
- EP Publication Date:
- 13/04/2005
- PCT Publication Date:
- 18/07/2002
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 03/12/2003
- EP B1 Publication Date:
- 13/04/2005
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 13/01/2006
- Expiration date:
- 13/01/2022
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 13/01/2002
- Name:
- Can-Fite Biopharma Ltd.
- Address:
- 10 Bareket Street, Petach Tikva 49170, Israel (IL)
Inventor
1
- Name:
- FISHMAN Pnina
- Address:
- Israel (IL)
2
- Name:
- KHALILI Kamel
- Address:
- United States (US)
Priority
- Priority Number:
- 261659 P
- Priority Date:
- 16/01/2001
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/7076;
| Filing date | Document type | Number of pages |
|---|